AVITA Medical, Inc. Form 8-K Summary
Business context and reporting period
AVITA Therapeutics, Inc. filed a Form 8-K on December 2, 2020, reporting a corporate name change. Effective that date, the company changed its name to AVITA Medical, Inc. The filing does not report quarterly or annual financial results.
Financial metrics and liquidity
The filing provides no information on revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material changes versus the prior comparable period
- The company amended its Delaware Certificate of Incorporation to change its corporate name from AVITA Therapeutics, Inc. to AVITA Medical, Inc.
- The company began the process of registering the name change with the Australian Securities and Investment Commission in connection with its Australian Securities Exchange listing.
- The company stated that related Australian market notices would be provided and that completion of the Australian registration process was expected to take several weeks.
Guidance, outlook, risks, contingencies, and unusual items
The filing contains no financial guidance or operating outlook. The principal administrative contingency is completion of the Australian corporate-name registration process. The company continued to identify its Nasdaq-listed common stock under the trading symbol RCEL.
Important facts to verify
- Confirm the effectiveness and scope of the Certificate of Amendment.
- Verify completion of the related Australian Securities and Investment Commission registration and any Australian market notices.
- Confirm whether the company’s Nasdaq trading symbol and other exchange listings changed after the filing.